Navigation Links
Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany
Date:12/27/2011

NEW YORK, Dec. 27, 2011 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Company has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT® Delivery system with Johann Wolfgang Goethe University Hospital (J.W. Goethe), a premier European cancer treatment and research center located in Frankfurt, Germany. Under the terms of the agreement, the Company will provide J.W. Goethe with logistics and clinical training support in the performance of chemosaturation therapy using the CHEMOSAT system. The Company expects to conduct the training using the Generation Two version of the CHEMOSAT system, pending CE Mark approval, and for training to begin at the J.W. Goethe University Hospital in February 2012.

University Professor Dr. Thomas J. Vogl, Director of the Institute for Diagnostic and Interventional Radiology at J.W. Goethe, said, "Our team is excited to bring use of the CHEMOSAT system to Germany. Clinical research suggests that chemosaturation therapy using the CHEMOSAT system will offer us a clinically significant tool in treating liver metastases with melphalan. We're eager to begin providing therapy to our patients and exploring the additional potential benefits that the newest generation product from Delcath provides.""This agreement marks another key milestone in the execution of our commercialization strategy for the CHEMOSAT system in the European Union," said Eamonn P. Hobbs, President and CEO of Delcath Systems. "Germany is the largest market in the EU and we are excited to be entering it with a partner as prestigious as J.W. Goethe. CHEMOSAT will be available to patients in Germany soon, and this latest agreement further positions us to begin realizing the system's potential throughout Europe in 2012."

About the Johann Wolfgang Goethe University HospitalFounded in 1914, J.W. Goethe
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
2. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
3. Delcath to Present at the Lazard Healthcare Conference on November 15
4. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
5. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
6. FDA Schedules Delcath Pre-New Drug Application Meeting Date
7. Delcath Announces Completion of Regulatory Notification Process in New Zealand
8. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
9. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
10. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
11. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., a ... the launch of their web site ( http://www.stephreports.com ... About STEPh Reports STEPh ... Each STEPh Report assesses the competitive ... projected launch year, company, and specific key issues.  STEPh ...
(Date:5/22/2013)... May 22, 2013   Upsher-Smith Laboratories, ... of its global Phase III clinical trial ... program for the management of epilepsy in ... USL255 is specifically engineered to provide convenient ... blood levels observed with currently available treatment ...
(Date:5/22/2013)... N.J. , May 22, 2013 MEDIFIRST ... opportunity to update shareholders about some recent company developments. ... expand its avenues of communication with shareholders. Integrating social ... launched a Facebook page and will post updates on ... Twitter hashtag is #medifirstusa. Says CEO ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Medifirst Solutions, Inc. Announces Update To Shareholders 2
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:5/22/2013)... 2013 The Muscular Dystrophy Association scored ... at the annual Charlotte Muscle Team event held May ... families living with muscle disease. , "The Charlotte ... support MDA families,” said MDA Divisional Director Theresa Miller. ... with a "Buddy" to make their night extra special, ...
(Date:5/22/2013)... Dennis Thompson HealthDay Reporter , , WEDNESDAY, May ... or back pain are more likely to attempt suicide, ... another psychiatric condition, according to a new study. ... should be aware they are at increased risk of ... Affairs Serious Mental Illness Treatment Resource and Evaluation Center ...
(Date:5/22/2013)... 22, 2013 Diversity Focus and Handicap ... The performance promotes awareness that physical disabilities do ... This! performance will be held Friday, June 14th at ... Tickets for Handicap This! can be purchased at ... measure the level to which their mind is handicap ...
(Date:5/22/2013)... in genomic health disparities from the University of Miami ... of Medicine have teamed up to hold the second ... Disparities in Genomic Medicine." The theme of this ... and government to reduce these disparities. , Despite steady ... individuals within underserved groups continue to be more vulnerable ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 Phelps ... established the Westchester Lung Nodule Center for individuals ... receive lung cancer care. Lung cancer is the deadliest form ... more people in the U.S. die from lung cancer than ... with all cancers, early detection increases survival rates. It ...
Breaking Medicine News(10 mins):Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3
... 4,000 people in the UK die each year from the effects of asbestos ... ... November 1999, the Government,s ban on the use of Asbestos came into force. ... die each year from the effects of asbestos exposure whilst at work. ...
... The Committee for Human,Medicinal Products (CHMP) ... once-daily dosing of 800 mg PREZISTA(R) (darunavir) ... in treatment-naive adults (those who,have never taken ... was,developed by Tibotec Pharmaceuticals, and Tibotec, a ...
... growth, experts say , , THURSDAY, Nov. 27 (HealthDay ... on your plate this Thanksgiving, because it may help protect ... Urological Association. , The high acid content in cranberries, ... simple UTIs, help inhibit bacterial growth along the urinary tract, ...
... 27 /PRNewswire-Asia-FirstCall/ -- China,s leading,integrated medical device and ... or "the Company", Stock Code: 8180.HK) is,pleased to ... in,Atlantis Investment Management Limited ("Atlantis Investment") as financial,investors ... shares at a price,HK$1.03 per share. , ...
... To coincide with Staying Alive,s tenth,anniversary on World AIDS ... of Travis McCoy, lead vocalist of the alternative,hip-hop band ... , Travis joins ... Beyonce, Mary J Blige, Justin Timberlake and Diddy, who ...
... healthcare services for seasonal vineyard workers and their families. In ... 2007 vintage. , ... Portland, OR (PRWEB) November 26, ... contributed generously to the 17th annual benefit with animated bidding on ...
Cached Medicine News:Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 2Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 2Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 4Health News:Cranberries May Help Prevent Urinary Tract Infections 2Health News:Golden Meditech Brings in Financial Investor Through New Share Issuance 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 3Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 4Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 5Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 6Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 2Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 3
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: